A 16S sequencing analysis of samples revealed that there were no differences in operational taxonomical unit (OTU) abundance and phylogeny in the gut microbiome of phage-treated and control pigs after 14 days of treatment.
OTU abundance in the microbiome of the ileum in antibiotictreated pigs differed signifi cantly (p < 0.05) from that of both phage-treated and control pigs, and the ileum in antibiotictreated pigs had signifi cantly higher percentages of clostridia and signifi cantly lower percentages of Lactobacilli compared to the ileum in control pigs. Several OTUs representing genera including Clostridium, Prevotella, and Helicobacter were over-or underrepresented in pigs in both the antibiotic and phage groups when compared to the control pigs. Taken together, these data indicate that phage therapy may affect intestinal microbiomes. Determining whether these changes are detrimental will necessitate further study.
Research advisor Paul Ebner writes: "Phage therapy holds a lot of promise in preventing different types of bacterial infections, but there are still many unanswered questions. Kyle's work begins to assess the impact these treatments may have on the host. Specifi cally, he looked at whether phage treatments affect surrounding, potentially benefi cial, bacteria."
